Skip to main content
Livermore
Livermore
ZHEN

Neuberger Berman Group LLC

SEC CIK
0001465109
Latest filing
Aug 13, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Neuberger Berman Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
559,445
Value
$277.9M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Neuberger Berman Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026559,445$277.9M0.2%+7,923+1.4%AddedHolders
Q1 2026551,522$246.3M0.2%+5,625+1.0%AddedHolders
Q4 2025545,897$247.5M0.2%+18,406+3.5%AddedHolders
Q3 2025527,491$206.6M0.2%+68,341+14.9%AddedHolders
Q2 2025459,150$204.4M0.2%+16,522+3.7%AddedHolders
Q1 2025442,628$214.6M0.2%+8,317+1.9%AddedHolders
Q4 2024434,311$174.9M0.1%+5,173+1.2%AddedHolders
Q3 2024429,138$199.6M0.2%+1,650+0.4%AddedHolders
Q2 2024427,488$200.4M0.2%+13,438+3.2%AddedHolders
Q1 2024414,050$173.1M0.1%+18,270+4.6%AddedHolders
Q4 2023395,780$161.0M0.1%+57,855+17.1%AddedHolders
Q3 2023337,925$117.5M0.1%+26,290+8.4%AddedHolders
Q2 2023311,635$109.7M0.1%+8,617+2.8%AddedHolders
Q1 2023303,018$95.5M0.1%+1,917+0.6%AddedHolders
Q4 2022301,101$87.0M0.1%+35,292+13.3%AddedHolders
Q3 2022265,809$77.0M0.1%−134,151−33.5%ReducedHolders
Q2 2022399,960$112.7M0.1%+157,191+64.7%AddedHolders
Q1 2022242,769$63.4M0.1%−420.0%ReducedHolders
Q4 2021242,811$52.4M<0.1%−43,385−15.2%ReducedHolders
Q3 2021286,196$51.6M<0.1%−123,143−30.1%ReducedHolders
Q2 2021409,339$82.3M0.1%+20,324+5.2%AddedHolders
Q1 2021389,015$83.3M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.